Skip to main content
SpringerLink
Log in

Complications of hip fracture surgery on patients receiving clopidogrel therapy

  • Orthopaedic Surgery
  • Published:
Archives of Orthopaedic and Trauma Surgery Aims and scope Submit manuscript

Abstract

Introduction

Clopidogrel (Plavix®) may influence patient safety during fracture surgery. Our study examines the incidence of complications for patients undergoing hemiarthroplasty on clopidogrel therapy.

Materials and methods

All patients, who underwent hemiarthroplasty between 2005 and 2011 were retrospectively reviewed. Patients were placed in two comparative groups based on the use of clopidogrel antiplatelet therapy. Records were reviewed for patient demographics, ASA score, pre and postoperative hemoglobin, time to surgery, length of stay, bleeding events, transfusions and complications. Comparative statistical analysis was performed using Fisher’s exact test and Student’s t test, using P < 0.05 to identify statistical significance.

Results

A total of 203 charts were reviewed, of which 162 patients met inclusion/exclusion criteria. One hundred and twelve females and 50 males with mean age of 84 years were identified. The clopidogrel group consisted of 15 (9.3 %) patients and the nonclopidogrel group 147 (90.7 %). The clopidogrel group had more comorbidities resulting in a significantly higher ASA score (3.9 vs. 2.9), and lower preoperative hemoglobin (11.3 vs. 12.0). There was no significant difference identified in time to surgery, intraoperative blood loss, hemoglobin on days 1–3, or number of transfusions received between groups. Patients on clopidogrel were seen to have significantly longer hospital stays (10.6 vs. 7.4 days). However, a similar rate of wound and bleeding related complications (6.7 vs. 6.1 %) was seen.

Conclusions

The optimal treatment for hip fracture patients on antiplatelet therapy is unclear. However, in this study there appears to be no significant difference with regards to bleeding and bleeding related wound complications, suggesting it is safe to proceed with hemiarthroplasty for patients receiving clopidogrel.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Al-Ani AN, Samuelsson B, Tidermark J et al (2008) Early operation on patients with a hip fracture improved the ability to return to independent living. A prospective study of 850 patients. J Bone Jt Surg Am 90(7):1436–1442

    Article  Google Scholar 

  2. Casaletto JA, Gatt R (2004) Post-operative mortality related to waiting time for hip fracture surgery. Injury 35(2):114–120

    Article  PubMed  Google Scholar 

  3. Chechik O, Amar E, Khashan M, Kadar A, Rosenblatt Y, Maman E (2012) In support of early surgery for hip fractures sustained by elderly patients taking clopidogrel: a retrospective study. Drugs Aging 29(1):63–68

    Article  PubMed  Google Scholar 

  4. Chechik O, Thein R, Fichman G, Haim A, Tov TB, Steinberg EL (2011) The effect of clopidogrel and aspirin on blood loss in hip fracture surgery. Injury 42(11):1277–1282

    Article  PubMed  Google Scholar 

  5. Collet JP, Montalescot G, Blanchet B et al (2004) Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 110(16):2361–2367

    Article  CAS  PubMed  Google Scholar 

  6. Collinge CA, Kelly KC, Little B, Weaver T, Schuster RD (2012) The effects of clopidogrel (Plavix) and other oral anticoagulants on early hip fracture surgery. J Orthop Trauma 26(10):568–573

    Article  PubMed  Google Scholar 

  7. Collyer TC, Reynolds HC, Truyens E, Kilshaw L, Corcoran T (2011) Perioperative management of clopidogrel therapy: the effects on in-hospital cardiac morbidity in older patients with hip fractures. Br J Anaesth 107(6):911–915

    Article  CAS  PubMed  Google Scholar 

  8. Cutlip DE, Baim DS, Ho KK et al (2001) Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 103(15):1967–1971

    Article  CAS  PubMed  Google Scholar 

  9. Dineen PF, Curtin RJ, Harty JA (2010) A review of the use of common antiplatelet agents in orthopaedic practice. J Bone Jt Surg Br 92(9):1186–1191

    Article  CAS  Google Scholar 

  10. Fisher A, Srikusalanukul W, Davis M, Smith P (2013) Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional links. Clin Interv Aging 8:239–256

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Fitchett D, Mazer CD, Eikelboom J, Verma S (2013) Antiplatelet therapy and cardiac surgery: review of recent evidence and clinical implications. Can J Cardiol 29:1042–1047

    Article  PubMed  Google Scholar 

  12. Galla JM, Lincoff AM (2007) The role of clopidogrel in the management of ischemic heart disease. Curr Opin Cardiol 22(4):273–279

    PubMed  Google Scholar 

  13. Gerber Y, Melton LJ, 3rd, McNallan SM, Jiang R, Weston SA, Roger VL (2013) Cardiovascular and noncardiovascular disease associations with hip fractures. Am J Med 126(2):169 e119–e126

    Google Scholar 

  14. Goodman LS, Brunton LL, Chabner B, Knollmann BrC (2011) Goodman & Gilman’s pharmacological basis of therapeutics. McGraw-Hill, New York

    Google Scholar 

  15. Harty JA, McKenna P, Moloney D, D’Souza L, Masterson E (2007) Anti-platelet agents and surgical delay in elderly patients with hip fractures. J Orthop Surg 15(3):270–272

    CAS  Google Scholar 

  16. Herman CR, Buth KJ, Kent BA, Hirsch GM (2010) Clopidogrel increases blood transfusion and hemorrhagic complications in patients undergoing cardiac surgery. Ann Thorac Surg 89(2):397–402

    Article  PubMed  Google Scholar 

  17. Hossain FS, Rambani R, Ribee H, Koch L (2013) Is discontinuation of clopidogrel necessary for intracapsular hip fracture surgery? Analysis of 102 hemiarthroplasties. J Orthop Traumatol Off J Ital Soc Orthop Traumatol 14:171–177

    Article  Google Scholar 

  18. Iakovou I, Schmidt T, Bonizzoni E et al (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293(17):2126–2130

    Article  CAS  PubMed  Google Scholar 

  19. Inman DS, Michla Y, Partington PF (2007) Perioperative management of trauma patients admitted on clopidogrel (Plavix). A survey of orthopaedic departments across the United Kingdom. Injury 38(5):625–630

    Article  PubMed  Google Scholar 

  20. Johansen A, White J, Turk A (2008) Clopidogrel therapy—implications for hip fracture surgery. Injury 39(10):1188–1190

    Article  PubMed  Google Scholar 

  21. Joseph JJ, Pillai A, Bramley D (2007) Clopidogrel in Orthopaedic patients: a review of current practice in Scotland. Thromb J 5:6

    Article  PubMed Central  PubMed  Google Scholar 

  22. Krotz F, Sohn HY, Klauss V (2008) Antiplatelet drugs in cardiological practice: established strategies and new developments. Vasc Health Risk Manag 4(3):637–645

    PubMed Central  PubMed  Google Scholar 

  23. Lai SW, Liao KF, Lai HC et al (2013) Risk of major osteoporotic fracture after cardiovascular disease: a population-based cohort study in Taiwan. J Epidemiol/Jpn Epidemiol Assoc 23(2):109–114

    Article  Google Scholar 

  24. Lavelle WF, Demers Lavelle EA, Uhl R (2008) Operative delay for orthopedic patients on clopidogrel (plavix): a complete lack of consensus. J Trauma 64(4):996–1000

    Article  CAS  PubMed  Google Scholar 

  25. Moran CG, Wenn RT, Sikand M, Taylor AM (2005) Early mortality after hip fracture: is delay before surgery important? J Bone Jt Surg Am 87(3):483–489

    Article  Google Scholar 

  26. Nydick JA, Farrell ED, Marcantonio AJ, Hume EL, Marburger R, Ostrum RF (2010) The use of clopidogrel (Plavix) in patients undergoing nonelective orthopaedic surgery. J Orthop Trauma 24(6):383–386

    Article  PubMed  Google Scholar 

  27. Palan J, Odutola A, White SP (2007) Is clopidogrel stopped prior to hip fracture surgery—a survey of current practice in the United Kingdom. Injury 38(11):1279–1285

    Article  PubMed  Google Scholar 

  28. Plosker GL, Lyseng-Williamson KA (2007) Clopidogrel: a review of its use in the prevention of thrombosis. Drugs 67(4):613–646

    Article  CAS  PubMed  Google Scholar 

  29. Sim W, Gonski PN (2009) The management of patients with hip fractures who are taking Clopidogrel. Australas J Ageing 28(4):194–197

    Article  PubMed  Google Scholar 

  30. Smith GH, Tsang J, Molyneux SG, White TO (2011) The hidden blood loss after hip fracture. Injury 42(2):133–135

    Article  CAS  PubMed  Google Scholar 

  31. Steele MJ, Fox JS, Fletcher JP, Grigg LE, Bell G (2011) Clopidogrel dilemma for orthopaedic surgeons. ANZ J Surg 81(11):774–784

    Article  PubMed  Google Scholar 

  32. Thaler HW, Frisee F, Korninger C (2010) Platelet aggregation inhibitors, platelet function testing, and blood loss in hip fracture surgery. J Trauma 69(5):1217–1220 discussion 1221

    Article  CAS  PubMed  Google Scholar 

  33. Vorobcsuk A, Aradi D, Farkasfalvi K, Horvath IG, Komocsi A (2012) Outcomes of patients receiving clopidogrel prior to cardiac surgery. Int J Cardiol 156(1):34–40

    Article  PubMed  Google Scholar 

  34. Weller I, Wai EK, Jaglal S, Kreder HJ (2005) The effect of hospital type and surgical delay on mortality after surgery for hip fracture. J Bone Jt Surg Br 87(3):361–366

    Article  CAS  Google Scholar 

  35. Willems JM, de Craen AJ, Nelissen RG, van Luijt PA, Westendorp RG, Blauw GJ (2012) Haemoglobin predicts length of hospital stay after hip fracture surgery in older patients. Maturitas 72(3):225–228

    Article  CAS  PubMed  Google Scholar 

  36. Wordsworth DR, Halsey T, Griffiths R, Parker MJ (2013) Clopidogrel has no effect on mortality from hip fracture. Injury 44(6):743–746

    Article  CAS  PubMed  Google Scholar 

  37. Zuckerman JD, Skovron ML, Koval KJ, Aharonoff G, Frankel VH (1995) Postoperative complications and mortality associated with operative delay in older patients who have a fracture of the hip. J Bone Jt Surg Am 77(10):1551–1556

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Robert Wood Johnson Medical School, 1 Robert Wood Johnson Place, New Brunswick, NJ, 08901, USA

    Moiz I. Manaqibwala, Katherine A. Butler & Carlos A. Sagebien

Authors
  1. Moiz I. Manaqibwala
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katherine A. Butler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carlos A. Sagebien
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Moiz I. Manaqibwala.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Manaqibwala, M.I., Butler, K.A. & Sagebien, C.A. Complications of hip fracture surgery on patients receiving clopidogrel therapy. Arch Orthop Trauma Surg 134, 747–753 (2014). https://doi.org/10.1007/s00402-014-1981-0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00402-014-1981-0

Keywords

Search

Navigation